Objectives: Our objectives were to describe the prevalence of arrhythmia and conduction abnormalities before critical care intubation and to test the hypothesis that atropine had no effect on their prevalence during intubation. Design: Prospective, observational study. Setting: PICU and pediatric/neonatal intensive care transport. Subjects: All children of age less than 8 years intubated September 2007September -2009. Subgroups of intubations with and without atropine were analyzed. Intervention: None. Measurement and Main Results: A total of 414 intubations were performed in the study period of which 327 were available for analysis (79%). Five children (1.5%) had arrhythmias prior to intubation and were excluded from the atropine analysis. Atropine was used in 47% (152/322) of intubations and resulted in significant acceleration of heart rate without provoking ventricular arrhythmias. New arrhythmias during intubation were related to bradycardia and were less common with atropine use (odds ratio, 0.14 [95% CI, 0.06-0.35], p < 0.001). The most common new arrhythmia was junctional rhythm. Acute bundle branch block was observed during three intubations; one Mobitz type 2 rhythm and five ventricular escape rhythms occurred in the no-atropine group (n = 170). Only one ventricular escape rhythm occurred in the atropine group (n = 152) in a child with an abnormal heart. One child died during intubation who had not received atropine. Conclusions: Atropine significantly reduced the prevalence of new arrhythmias during intubation particularly for children over 1 month of age, did not convert sinus tachycardia to ventricular tachycardia or fibrillation, and may contribute to the safety of intubation. (Pediatr Crit Care Med 2013; 14:e289-e297) 
P ediatric critical care (1, 2) and anesthetic intubation (3) may result in slowing of the heart. The causes of this are two-fold. First, reflex stimulation of afferent fibers of the vagus nerve occurs due to the hypoxia and/or mechanical stimulation of the laryngopharynx with vagal efferent fibers secreting acetylcholine in the sinoatrial node (4) . Second, the use of various induction drugs such as halothane (5) , rapidly acting morphine analogs, sufentanil and remifentanil (6, 7) , propofol (8) , or the muscle relaxant suxamethonium (9) also tend to slow heart rate and induce bradycardia-related arrhythmias.
Atropine was proposed in the 1950s to limit bradycardia due to its antagonistic action on the postsynaptic acetylcholine receptor (9) . In normal children, atropine cardiotoxicity is limited to sinus tachycardia (4, 10, 11) . During routine anesthesia, atropine has been associated with ventricular extrasystoles and rarely ventricular tachycardia (12) and ; Rym Boulkedid, PhD 2, 5 ; Mark J. Peters, FRCPCH, PhD 1 fibrillation (13) . Indeed, one study concluded that the prevalence of ventricular arrhythmias was so high with atropine that its use during routine anesthesia should be "reconsidered" (14) . By the 1990s atropine was no longer used for routine anesthetic induction (15) .
Recently, however, atropine has been recommended for the maintenance of hemodynamic integrity in intensive care populations by several authors but without knowing whether it is effective in stabilizing the circulation and its potential cardiac side effects (16, 17) .
Our objectives were to describe the prevalence of arrhythmia before critical care intubation and test the hypothesis that atropine had no effect on the prevalence of new arrhythmias or conduction abnormalities in this scenario.
METHODS

Study Design
This prospective, observational study was approved by the All intubations of children who were not asystolic and were of age less than 8 years were eligible for inclusion. Children above 8 years were not included as the hospital protocol was not to administer atropine routinely over that age. The prescription of atropine (hospital protocol for the minimum dose was 20 μg/kg) and induction drugs was at the discretion of the intensivist, but the decision to use atropine could be made by a junior performing the intubation.
The following data were prospectively recorded: age, sex, pathology (neonatal respiratory distress [NRD] ; non-neonatal respiratory distress [non-NRD]; cardiac; neurological; ear, nose, and throat; sepsis; and "other"), the principal induction drug, and atropine prescription. Intubations where atropine was used after the start of the intubation were included in the no-atropine group on the basis of the intention "not to treat."
Study Procedures
A 1-minute electrocardiogram (ECG) baseline strip (25 mm/s) was recorded prior to the start of intubation. If atropine was administered, a second preintubation strip of 60 seconds was recorded 2 minutes after the injection of atropine. Continuous ECG and oxygen saturation (Spo 2 ) recording started from the moment of insertion of the laryngoscope to positioning of the endotracheal tube in the trachea and Spo 2 of greater than 95%, or connection to a ventilator. The number of attempts at intubation was recorded on the ECG by the intensivist.
Two pediatric intensivists, who were not blinded to atropine treatment, reviewed the ECGs independently. An average was made of their readings of the baseline heart rate, at 2 minutes after atropine administration and at the lowest two R-R complexes during intubation. All potential episodes of arrhythmia were recorded for review by an electrophysiologist who was blinded to atropine treatment. A random sample of 10% of the ECG recordings that were considered to be normal by the two intensivists was also examined by the electrophysiologist to control for false negatives.
Sinus bradycardia/tachycardia was regarded as a normal rhythm. Abnormal rhythms were considered to be atrial or ventricular extrasystoles, ectopic rhythm, ventricular tachycardia, or fibrillation. Abnormalities of conduction were also noted.
Patients who were not in sinus rhythm at baseline were excluded from analysis of atropine effect. The remaining cases were divided into the two groups: atropine and no atropine. Additional subgroups were created of neonatal (<28 d postnatal age), older children (>28 d postnatal age), and further intubations (of all ages). Further intubations were on patients who had previously been intubated in the study period or had a change of endotracheal tube. The primary analysis included all intubations. A secondary analysis was performed of the first intubations so as not to eliminate the bias of including further intubations. The rationale of dividing the group at 28 days was due to the physiological transition in autonomic innervation from predominant parasympathetic to codominance that occurs during early extrauterine life (18) .
Statistical Analysis
Qualitative variables are described as numbers and percentages and quantitative variables as median (interquartile range) or mean (standard deviation) according to their Gaussian distribution. Independent and paired t tests were used for continuous data, a chi-square test was used for categorical data where there were three or more variables, and Fisher exact test where there were two variables. All statistical tests were two-sided, and the probability of a type 1 error (α) was determined at less than 0.05. Univariate and stepwise multivariable logistic regression (using variables of univariate significance p < 0.20) models were constructed to test the effect of atropine and other preintubation variables on the occurrence of ECG abnormalities using a maximum of one covariate per 10 events. Odds ratios (OR) were calculated for categorical variables with their corresponding 95% CI. All statistical tests were carried out using SAS V.9.2 software (SAS, Cary, NC).
RESULTS
Four hundred and fourteen intubations were eligible for inclusion. Sixty intubations were not included, generally due to urgency or high workload conditions, and twenty-seven intubations were subsequently excluded, generally due to poor quality recordings ( The prevalence of baseline arrhythmia before the start of intubation was 1.5% (5/327). One case had frequent bursts of ventricular tachycardia interspersed by junctional rhythm due to leukemic infiltration of the heart and died some hours after intubation. In another case, child was intubated during ventricular fibrillation in the context of Shigella septicaemia and multiple organ failure. Two cases had long-standing left bundle branch block from a cardiac malformations, and one other case had an atrial ectopic beat. All these five cases were excluded from the subsequent analysis.
A total of 322 intubations were analyzed for the effect of atropine on the emergence of new arrhythmias and conduction disturbances during intubation. Atropine was used in 47% (152/322) intubations, and 53% (170/322) of intubations were without atropine (Fig. 1) . Atropine was used in a similar proportion (p = 0.12) of cases in each of the three subgroups (neonatal, >28 d, and PICU) ( Table 1) . One child of age 18 months died during intubation with a lethal chromosomal disorder, pulmonary hypertension, and sepsis, and who had not received atropine.
There was no significant difference between the median number of attempts at intubation with atropine and without atropine (1 [ Fifty-five ECGs were identified by the intensivists as being abnormal of which 48 were confirmed by the electrophysiologist as being abnormal. None of the ECGs considered to be normal by the intensivists were considered to be abnormal by the electrophysiologist giving 100% selectivity with 87% specificity.
After the administration of atropine, before intubation, the mean heart rate of all patients rose from 153 beats/ min During intubation, the mean lowest heart rate was significantly decreased for all patients when atropine was not used ( Table 2) , and junctional and atrial ectopic rhythms were significantly more frequent ( Table 2 ). The overall frequency of ECG abnormalities was higher when atropine was not used (Tables 2 and 3 ). The ECGs of all patients returned to sinus rhythm before the end of recording with the exception of the child who died.
To test for the interference of the further intubations, a post hoc analysis of the first intubations of neonates and older children was performed, which confirmed the effect of atropine in reducing new arrhythmias and/or conduction disturbances (OR, 0.10 [95% CI, 0.03-0.35], p < 0.001). A post hoc analysis was also performed to examine the effect of postconception age versus postnatal age. No effect was observed on the significance of either the p value for the difference among the ages of the children included or the odds ratio and the p value for the effect of atropine on new arrhythmias.
DISCUSSION
Arrhythmias and conduction disturbances were prevalent in 1.5% (5/327) of children prior to intubation. We disproved our hypothesis and showed that there was a significantly The highly statistically significant effect that atropine had on reducing the frequency of new arrhythmias and conduction disturbances appears to relate to its capacity to prevent bradycardia (Tables 2 and 3; Fig. 2) . Of the 21 intubations where the heart rate fell below 60 beats/min, 76% exhibited new arrhythmias and conduction disturbances (Fig. 2) . The older children (19/61, 31%) and further intubations (11/41, 27%) tended to receive less atropine and experienced proportionately more new arrhythmias than did the neonates (8/68, 12%). This is at variance with the opinions of McAllister and Gnauck (19) , when discussing arrhythmia, who stated that "infants are at greater risk than older children for bradycardia-induced hemodynamic compromise." Having established a link between atropine and a reduction in arrhythmia, this result should ideally be confirmed in a study using randomized methodology. Our results could be used to facilitate power calculations for such a study. Such a study is feasible although may result in an inferior inclusion rate to ours (79%).
All the new intubation ECG abnormalities observed fell into three categories: atrial ectopic rhythms, sinoatrial pause accompanied by ventricular escape rhythm, and impulse conduction abnormalities (Fig. 3) . Ectopic atrial and junctional pacemakers have previously been shown to be relatively frequent in pediatric anesthetic studies (14, 20, 21) . Ventricular filling is little compromised by atrial ectopic pacemakers under normal circumstances because 70-80% of ventricular filling is passive (22) although this may not be the case for the hyperdynamic circulation. The ectopic atrial contractions that are transmitted through the atrioventricular junction are generally blocked from inducing ventricular contractions by the relatively long refractory period of the Purkinje fibers (23) . But when the ventricular myocardium is deprived of coordinated impulses from the atria, ventricular escape rhythms may develop (Fig. 3) . Ectopic ventricular contractions may additionally reduce contractile efficiency by the propagation of suboptimal action potentials among ventricular myocytes. This may generate a negative feedback loop of poor cardiac output and myocardial ischemia above and above the hypoperfusion of severe sinus bradycardia (24) . Acute bundle branch block is an important finding, which was noted in three patients all of whom were being intubated for septic shock. Acute bundle branch block is a risk for progression to sudden and complete heart block that can be fatal (25) . The occurrence of a second-degree 2:1 atrioventricular block (Mobitz type 2) during one reintubation represents an abrupt failure of atrioventricular conduction and is also a potential risk for complete heart block and asystole (Fig. 3) (26) .
Reports of cardiotoxicity in normal hearts (other than sinus tachycardia) following atropine are rare (4, 10, 11) . We demonstrated that preexisting sinus tachycardia did not progress to ventricular arrhythmia in the 152 intubations with atropine. This contrasts with a relatively high frequency of ventricular extrasystoles and other ventricular escape rhythms observed in previous anesthetic studies with atropine. We speculate that interactions between atropine and inhalational agents used in these studies may be important (5) .
The relative contributions of induction drugs to the creation of new arrhythmias show that etomidate (multivariate analysis) and ketamine (univariate analysis) have a tendency to induce arrhythmias compared with "no drugs," and propofol tends to be protective (Table 3) . These results should be interpreted with caution for two reasons: first, etomidate and ketamine were used predominantly in septic shock and propofol for non-NRD pathologies; second, the majority of children intubated without drugs were neonates (Table 1) .
Several possible sources of bias are present in our study. An inequality in the casemix of the two groups exists with a higher proportion of younger children and those with lower heart rates receiving more atropine (Table 1) . Other imbalances between the two groups include the use of propofol that was more frequently used in the older children and has been previously associated with bradycardia (27) . Overall, the use of muscle relaxants was low. This is due to three reasons. First, the relatively high number of neonates (practice in the hospital, and Paris Region, was not to paralyze during the study years); second, the relatively frequent use of propofol that gives good intubation conditions without muscle relaxants (28) ; and finally, the PICU practice that traditionally had a high-case load of ENT patients who are generally intubated without muscle relaxation. The decision to use atropine may have been influenced by the experience of the intensivist. Most intubations involved a senior and a junior, and the process of decision making was difficult to evaluate. The inclusion of a "further" intubation group meant some children with longer illnesses were entered into the study several times. We, therefore, presented the results as a further intubation subgroup to exclude bias from further intubations. The advantage of examining the reintubations is that they represent real-life practice, and this approach has been adopted in other intubation studies (2) . The post-hoc analysis of postnatal versus postconceptual age did not influence the results because relatively few neonates intubated by the transport team were preterm; the potentially premature births have been transferred prenatally to level III centers. The intubation conditions regarding the number of attempts at intubation were similar for the groups with and without atropine. These were similar to those previously described in neonatal (1, 29, 30) and pediatric studies (2, 31 ). An exception is the median trough saturation in our group of older children, which was lower than in two other studies (2, 31) . However, these studies mention that the retrospective nature of their methodologies was a cause of possible bias in this respect. Although not all children received sedation drugs or experienced lowering oxygen saturation, all children received laryngoscopy. As such it is not possible using our methodology to deduce whether bradycardia was due to hypoxia, laryngoscopy, or sedation drugs. With the exception of chronic bundle branch block in C, all electrocardiograms were in normal sinus rhythm before the start of intubation; A, acute bundle branch block, sinus pause followed by ventricular extrasystole; b, infranodal block, Mobitz type 2; C, chronic bundle branch block with atrial ectopic pacemaker; D, sinus pause with ventricular escape rhythm and atrial trigeminism; E, sinus bradycardia followed by junctional rhythm; F, sinus pause with ventricular escape rhythm followed by asystole; G, sinus pause with junctional extrasystole followed by ventricular escape rhythm.
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CONCLUSIONS
Atropine reduces the prevalence of arrhythmias and conduction disturbances during intubations, which may contribute to the safety of the procedure during pediatric critical illness. The decrease in heart rate during intubation was similar in neonates and children of age over 1 month when atropine was not used although the older children experienced more arrhythmias. This suggests that low heart rate may not be the sole contributing factor to arrhythmogenesis. Atropine did not provoke any new arrhythmias during the minute of recording 2 minutes after administration but before intubation. 
